Aptus Capital Advisors, LLC Merck & Co., Inc. Transaction History

Aptus Capital Advisors, LLC

$4.95 Billion
Q1 2024

A detailed history of Aptus Capital Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aptus Capital Advisors, LLC holds 82,327 shares of MRK stock, worth $10.4 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

82,327

Previous 72,321 13.84%

Holding current value

$10.4 Million

Previous $7.88 Million 37.79%

% of portfolio

0.22%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $1.13 Million - $1.32 Million	10,006 Added 13.84%	82,327 $10.9 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $126,627 - $137,801	-1,264 Reduced 1.72%	72,321 $7.88 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $288,774 - $320,695	2,805 Added 3.96%	73,585 $7.58 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $460,940 - $502,404	-4,244 Reduced 5.66%	70,780 $8.17 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $1.57 Million - $1.75 Million	-15,216 Reduced 16.86%	75,024 $7.98 Million

Q4 2022 Feb 13, 2023	BUY	$87.44 - $112.11 $1.04 Million - $1.34 Million	11,925 Added 15.23%	90,240 $10 Million
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $273,285 - $307,005	3,233 Added 4.31%	78,315 $6.76 Million
Q2 2022 Jul 29, 2022	BUY	$83.49 - $94.64 $3.15 Million - $3.57 Million	37,678 Added 100.73%	75,082 $6.86 Million
Q1 2022 May 04, 2022	BUY	$73.51 - $82.4 $2.14 Million - $2.4 Million	29,131 Added 352.12%	37,404 $3.08 Million
Q4 2021 Feb 02, 2022	SELL	$72.28 - $90.54 $32,742 - $41,014	-453 Reduced 5.19%	8,273 $638,000
Q3 2021 Oct 27, 2021	SELL	$71.68 - $78.83 $2.19 Million - $2.41 Million	-30,585 Reduced 77.8%	8,726 $660,000
Q2 2021 Jul 27, 2021	BUY	$70.31 - $77.77 $367,299 - $406,270	5,224 Added 15.33%	39,311 $3.06 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $2,685 - $3,163	-39 Reduced 0.11%	34,087 $2.63 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $18,947 - $21,027	-264 Reduced 0.77%	34,126 $2.8 Million
Q3 2020 Oct 19, 2020	BUY	$73.18 - $82.95 $1.98 Million - $2.25 Million	27,101 Added 371.81%	34,390 $2.86 Million
Q2 2020 Jul 22, 2020	SELL	$70.42 - $80.13 $9,647 - $10,977	-137 Reduced 1.84%	7,289 $563,000
Q1 2020 May 07, 2020	SELL	$63.36 - $87.82 $5,639 - $7,815	-89 Reduced 1.18%	7,426 $571,000
Q4 2019 Feb 10, 2020	BUY	$77.58 - $87.54 $303,725 - $342,719	3,915 Added 108.75%	7,515 $683,000
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $7,531 - $8,210	99 Added 2.83%	3,600 $303,000
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $65,160 - $76,123	933 Added 36.33%	3,501 $293,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $178,681 - $203,796	2,568 New	2,568 $213,000

Others Institutions Holding MRK

# of Institutions

3,769

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $320B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aptus Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aptus Capital Advisors, LLC with notifications on news.

Account

Aptus Capital Advisors, LLC Merck & Co., Inc. Transaction History